Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/27169
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlexander W.S.en
dc.contributor.authorRogers K.en
dc.contributor.authorTarlinton D.M.en
dc.contributor.authorSmyth G.K.en
dc.contributor.authorDavis M.J.en
dc.contributor.authorNutt S.L.en
dc.contributor.authorNg A.P.en
dc.contributor.authorCoughlan H.D.en
dc.contributor.authorHediyeh-zadeh S.en
dc.contributor.authorBehrens K.en
dc.contributor.authorJohanson T.M.en
dc.contributor.authorLow M.S.Y.en
dc.contributor.authorBell C.C.en
dc.contributor.authorGilan O.en
dc.contributor.authorChan Y.-C.en
dc.contributor.authorKueh A.J.en
dc.contributor.authorBoudier T.en
dc.contributor.authorFeltham R.en
dc.contributor.authorGabrielyan A.en
dc.contributor.authorDiRago L.en
dc.contributor.authorHyland C.D.en
dc.contributor.authorIerino H.en
dc.contributor.authorMifsud S.en
dc.contributor.authorViney E.en
dc.contributor.authorWillson T.en
dc.contributor.authorDawson M.A.en
dc.contributor.authorAllan R.S.en
dc.contributor.authorHerold M.J.en
dc.date.accessioned2021-05-14T09:06:18Zen
dc.date.available2021-05-14T09:06:18Zen
dc.date.copyright2020en
dc.date.created20200916en
dc.date.issued2020-09-16en
dc.identifier.citationNature Communications. 11 (1) (no pagination), 2020. Article Number: 3013. Date of Publication: 01 Dec 2020.en
dc.identifier.issn2041-1723 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/27169en
dc.description.abstractB lymphoid development is initiated by the differentiation of hematopoietic stem cells into lineage committed progenitors, ultimately generating mature B cells. This highly regulated process generates clonal immunological diversity via recombination of immunoglobulin V, D and J gene segments. While several transcription factors that control B cell development and V(D)J recombination have been defined, how these processes are initiated and coordinated into a precise regulatory network remains poorly understood. Here, we show that the transcription factor ETS Related Gene (Erg) is essential for early B lymphoid differentiation. Erg initiates a transcriptional network involving the B cell lineage defining genes, Ebf1 and Pax5, which directly promotes expression of key genes involved in V(D)J recombination and formation of the B cell receptor. Complementation of Erg deficiency with a productively rearranged immunoglobulin gene rescued B lineage development, demonstrating that Erg is an essential and stage-specific regulator of the gene regulatory network controlling B lymphopoiesis.Copyright © 2020, The Author(s).en
dc.languageEnglishen
dc.languageenen
dc.publisherNature Researchen
dc.relation.ispartofNature Communicationsen
dc.subject.meshB lymphocyte-
dc.subject.meshcell differentiation-
dc.subject.meshcell maturation-
dc.subject.meshgene expression-
dc.subject.meshgene regulatory network-
dc.subject.meshgenetic complementation-
dc.subject.meshimmunoglobulin gene-
dc.subject.meshlymphoid progenitor cell-
dc.subject.meshlymphopoiesis-
dc.subject.meshtranscription regulation-
dc.subject.meshVDJ recombination-
dc.subject.meshB lymphocyte receptor-
dc.subject.meshCD19 antigen-
dc.subject.meshCD22 antigen-
dc.subject.meshCD3 antigen-
dc.subject.meshCD40 ligand-
dc.subject.meshCD79a antigen-
dc.subject.meshCD79b antigen-
dc.subject.meshcre recombinase-
dc.subject.meshDNA dependent protein kinase-
dc.subject.meshfibrinogen receptor-
dc.subject.meshimmunoglobulin D-
dc.subject.meshimmunoglobulin G1-
dc.subject.meshimmunoglobulin M-
dc.subject.meshinterferon regulatory factor 4-
dc.subject.meshinterleukin 2 receptor alpha-
dc.subject.meshinterleukin 4-
dc.subject.meshinterleukin 5-
dc.subject.meshleukosialin-
dc.subject.meshlymphoid enhancer factor 1-
dc.subject.meshMyc protein-
dc.subject.meshprotein Myb-
dc.subject.meshRAG1 protein-
dc.subject.meshtranscription factor 7 like 1-
dc.subject.meshtranscription factor ERG-
dc.subject.meshtranscription factor PAX5-
dc.subject.meshBach2 protein-
dc.subject.meshPou2af1 protein-
dc.subject.meshtranscription factor Ebf1-
dc.subject.meshvpreb2 protein-
dc.subject.meshCD4 antigen-
dc.titleAn Erg-driven transcriptional program controls B cell lymphopoiesis.en
dc.typeArticleen
dc.identifier.affiliationHaematology-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/s41467-020-16828-y-
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid32541654 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32541654]en
dc.identifier.source2005229685en
dc.identifier.institution(Ng, Behrens, Kueh, DiRago, Hyland, Ierino, Mifsud, Viney, Willson, Herold, Alexander) Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia (Ng, Coughlan, Johanson, Low, Kueh, Boudier, Allan, Herold, Rogers, Smyth, Davis, Nutt, Alexander) Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia (Coughlan, Hediyeh-zadeh, Smyth, Davis) Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia (Johanson, Low, Allan, Nutt) Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia (Low) Monash Haematology, Monash Hospital, Clayton, VIC 3004, Australia (Bell, Gilan, Chan, Dawson) Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia (Bell, Gilan, Chan, Dawson) Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia (Boudier, Rogers) Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia (Feltham, Gabrielyan) Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3010, Australia (Dawson) Centre for Cancer Research, The University of Melbourne, Parkville, VIC 3010, Australia (Tarlinton) Department of Immunology and Pathology, Monash University, Melbourne, VIC 3004, Australiaen
dc.description.addressA.P. Ng, Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia. E-mail: ang@wehi.edu.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2021 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailNg A.P.; ang@wehi.edu.auen
dc.description.grantOrganization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australiaen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
Appears in Collections:Articles
Show simple item record

Page view(s)

10
checked on Sep 17, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.